110 related articles for article (PubMed ID: 38822674)
1. Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer.
Berza N; Zodzika J; Kivite-Urtane A; Baltzer N; Curkste A; Pole I; Nygård M; Pärna K; Stankunas M; Tisler A; Uuskula A
Eur J Public Health; 2024 May; ():. PubMed ID: 38822674
[TBL] [Abstract][Full Text] [Related]
2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
4. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
[TBL] [Abstract][Full Text] [Related]
5. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
Shen J; Gao LL; Zhang Y; Han LL; Wang JD
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
[No Abstract] [Full Text] [Related]
7. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda.
Nang DW; Tukirinawe H; Okello M; Tayebwa B; Theophilus P; Sikakulya FK; Fajardo Y; Afodun AM; Kajabwangu R
BMC Womens Health; 2023 Apr; 23(1):209. PubMed ID: 37118735
[TBL] [Abstract][Full Text] [Related]
9. Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.
Agorastos T; Chatzistamatiou K; Katsamagkas T; Koliopoulos G; Daponte A; Constantinidis T; Constantinidis TC;
PLoS One; 2015; 10(3):e0119755. PubMed ID: 25793281
[TBL] [Abstract][Full Text] [Related]
10. p16/Ki-67 co-expression associates high risk human papillomavirus persistence and cervical histopathology: a 3-year cohort study in China.
Yu LL; Guo HQ; Lei XQ; Qin Y; Wu ZN; Kang LN; Zhang X; Qiao YL; Chen W
Oncotarget; 2016 Oct; 7(40):64810-64819. PubMed ID: 27588487
[TBL] [Abstract][Full Text] [Related]
11. Oral Human Papillomavirus Prevalence and Genotyping Among a Healthy Adult Population in the US.
Giuliano AR; Felsher M; Waterboer T; Mirghani H; Mehanna H; Roberts C; Chen YT; Lynam M; Pedrós M; Sanchez E; Sirak B; Surati S; Alemany L; Morais E; Pavón MA
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):783-795. PubMed ID: 37535349
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
Lazcano-Ponce E; Lörincz AT; Salmerón J; Fernández I; Cruz A; Hernández P; Mejia I; Hernández-Avila M
Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376
[TBL] [Abstract][Full Text] [Related]
13. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
Feng T; Cheng B; Sun W; Yang Y
BMC Womens Health; 2023 Nov; 23(1):599. PubMed ID: 37957634
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of partial HPV16/18 genotyping in stratifying HPV-positive women attending routine cervical cancer screening: a population-based cohort study.
Gori S; Battagello J; Gustinucci D; Campari C; Zorzi M; Frayle H; Passamonti B; Sartori G; Bulletti S; Fodero C; Cesarini E; Faggiano R; Del Mistro A
BJOG; 2021 Jul; 128(8):1353-1362. PubMed ID: 33326680
[TBL] [Abstract][Full Text] [Related]
15. Correlation of human papilloma virus infection with cytology, colposcopy and histopathological examination of the bioptic tissue in low- and high-grade intraepithelial lesions.
Jovanović AM; Dikic SD; Jovanovic V; Zamurovic M; Nikolic B; Krsic V; Rakic S; Stanimirovic B
Eur J Gynaecol Oncol; 2012; 33(5):512-6. PubMed ID: 23185799
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
[No Abstract] [Full Text] [Related]
17. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, Genotype Distribution and Risk Factors for Cervical Human Papillomavirus Infection in the Grand Tunis Region, Tunisia.
Ardhaoui M; Ennaifer E; Letaief H; Salsabil R; Lassili T; Chahed K; Bougatef S; Bahrini A; El Fehri E; Ouerhani K; Paez Jimenez A; Guizani I; Boubaker MS; Ben Alaya NB
PLoS One; 2016; 11(6):e0157432. PubMed ID: 27299955
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Potential Predictors, and Genotype-Specific Prevalence of Human Papillomavirus Infection among Sexually Active Students in Japan.
Imai H; Nakao H; Shinohara H; Watarai M; Matsumoto N; Yamagishi T; Saito M; Kitamura T
PLoS One; 2015; 10(7):e0132462. PubMed ID: 26176861
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.
Giambi C; Donati S; Carozzi F; Salmaso S; Declich S; Atti ML; Ronco G; Alibrandi MP; Brezzi S; Collina N; Franchi D; Lattanzi A; Minna MC; Nannini R; Barretta E; Burroni E; Gillio-Tos A; Macallini V; Pierotti P; Bella A
BMC Infect Dis; 2013 Feb; 13():74. PubMed ID: 23390953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]